Financial Performance - Net profit attributable to shareholders rose by 15.30% to CNY 185,008,066.62 year-on-year[9] - Operating revenue grew by 6.76% to CNY 3,615,522,584.15 compared to the same period last year[9] - Basic earnings per share increased by 14.52% to CNY 0.71 compared to the same period last year[9] - The company reported a net profit after deducting non-recurring gains and losses of CNY 176,448,906.30, an increase of 14.15% year-on-year[9] - Net profit for Q1 2020 reached CNY 199,227,472.55, compared to CNY 172,050,742.27 in Q1 2019, representing a growth of 15.83%[32] - Total comprehensive income for Q1 2020 was CNY 199,227,472.55, up from CNY 172,050,742.27 in Q1 2019, reflecting a growth of 15.83%[32] Assets and Liabilities - Total assets increased by 11.73% to CNY 13,360,542,746.47 compared to the end of the previous year[9] - Total current assets reached ¥11,493,875,340.56, up from ¥10,094,286,331.65 at the beginning of the year[22] - Total liabilities amounted to ¥8,350,886,445.05, compared to ¥7,300,692,331.02, indicating an increase of around 14.4%[26] - Current liabilities rose to ¥7,410,437,848.97 from ¥6,872,726,085.58, reflecting an increase of about 7.8%[25] - The company's equity increased to ¥5,009,656,301.42 from ¥4,657,521,642.40, reflecting a growth of approximately 7.5%[26] Cash Flow - Net cash flow from operating activities decreased by 132.14% to -CNY 707,387,815.80 compared to the previous year[9] - The net cash flow from operating activities for the period was -¥707,387,815.80, worsening from -¥304,725,812.76 in the same period last year[18] - Cash received from sales of goods and services was CNY 3,059,815,503.18, an increase from CNY 2,753,451,562.07 in Q1 2019[35] - Cash flow from investing activities showed a net outflow of CNY -518,982,167.18, compared to CNY -321,657,714.98 in Q1 2019[37] - Cash inflow from financing activities totaled CNY 1,908,700,000.00, significantly higher than CNY 810,082,607.94 in the previous year[37] Shareholder Information - The total number of shareholders at the end of the reporting period was 20,138[13] - The largest shareholder, Zhu Chaoyang, holds 27.86% of the shares, totaling 72,166,282 shares[13] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 9,696,105.74 during the reporting period[11] - Other income surged by 942.89% to ¥5,316,948.34, attributed to an increase in government subsidies recognized as other income[18] Borrowings and Financial Expenses - Short-term borrowings rose by 31.92% to ¥2,491,550,000.00, mainly due to increased bank loans during the period[18] - Financial expenses for Q1 2020 were CNY 32,413,254.38, compared to CNY 29,479,594.81 in Q1 2019, showing an increase of 6.56%[31] Inventory and Accounts Receivable - Accounts receivable increased to ¥7,097,186,661.54 from ¥5,989,376,716.39, indicating a growth in sales or credit terms[22] - Inventory rose to ¥1,619,284,659.02 from ¥1,508,922,641.63, reflecting increased stock levels[22]
柳药集团(603368) - 2020 Q1 - 季度财报